Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I neoadjuvant DCF in elderly resectable esophageal cancer
jRCTs061240067Phase 1Recruiting
- Start
- Oct 2024
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of docetaxel, cisplatin and fluorouracil in esophageal cancer. Primary endpoint: DLT occurrence rate at each dose level. Started Oct 2024; status: recruiting.
02
Drugs
docetaxelcisplatinfluorouracil
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on jRCTs061240067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061240067.